{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:34:20Z","timestamp":1780479260110,"version":"3.54.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate placenta accreta spectrum with and without placenta previa with regard to risk factors, antepartum diagnosis, and maternal morbidity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a retrospective cohort study of pathology-confirmed placenta accreta spectrum deliveries with hysterectomy from two U.S. referral centers from January 2010\u2013June 2019. Maternal, pregnancy, and delivery characteristics were compared among placenta accreta spectrum cases with (previa PAS group) and without (nonprevia PAS group) placenta previa. Surgical outcomes and a composite of severe maternal morbidities were evaluated, including eight or more blood cell units transfused, reoperation, pulmonary edema, acute kidney injury, thromboembolism, or death. Logistic regression was used with all analyses controlled for delivery location.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 351 deliveries, 106 (30%) had no placenta previa at delivery. When compared with the previa group, nonprevia placenta accreta spectrum was less likely to be identified antepartum (38%, 95% CI 28\u201348% vs 87%, 82\u201391%), less likely to receive care from a multidisciplinary team (41%, 31\u201351% vs 86%, 81\u201390%), and less likely to have invasive placenta increta or percreta (51% 41\u201361% vs 80%, 74\u201384%). The nonprevia group had more operative hysteroscopy (24%, 16\u201333% vs 6%, 3\u20139%) or in vitro fertilization (31%, 22\u201341% vs 9%, 6\u201313%) and was less likely to have had a prior cesarean delivery (64%, 54\u201373% vs 93%, 89\u201396%) compared with the previa group, though the majority in each group had a prior cesarean delivery. Rates of severe maternal morbidity were similar in the two groups, at 19% (nonprevia) and 20% (previa), even after controlling for confounders (adjusted odds ratio for the nonprevia group 0.59, 95% CI 0.30\u20131.17).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Placenta accreta spectrum without previa is less likely to be diagnosed antepartum, potentially missing the opportunity for multidisciplinary team management. Despite the absence of placenta previa and less placental invasion, severe maternal morbidity at delivery was not lower. Broader recognition of patients at risk for placenta accreta spectrum may improve early clinical diagnosis and patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003970","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:29:07Z","timestamp":1596731347000},"page":"458-465","source":"Crossref","is-referenced-by-count":67,"title":["Placenta Accreta Spectrum Without Placenta Previa"],"prefix":"10.1097","volume":"136","author":[{"given":"Daniela A.","family":"Carusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre J.","family":"Lyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola C.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Aalipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.","family":"Einerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza A.","family":"Shamshirsaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"R1-20230713","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2015.04.034","article-title":"Conservative management of morbidly adherent placenta: expert review","volume":"213","author":"Fox","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230713","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2017.02.016","article-title":"Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time","volume":"216","author":"Shamshirsaz","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230713","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.ajog.2014.08.019","article-title":"Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach","volume":"212","author":"Shamshirsaz","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20230713","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajog.2019.02.054","article-title":"Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta","volume":"220","author":"Collins","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230713","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2019.05.035","article-title":"Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team","volume":"221","author":"Erfani","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20230713","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/GRF.0000000000000391","article-title":"The placenta accreta spectrum: epidemiology and risk factors","volume":"61","author":"Carusi","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"R7-20230713","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"Maternal morbidity associated with multiple repeat cesarean deliveries","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R8-20230713","doi-asserted-by":"crossref","first-page":"36.e1","DOI":"10.1016\/j.ajog.2008.03.007","article-title":"Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery","volume":"199","author":"Clark","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230713","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/1471-0528.15306","article-title":"Placenta praevia and placenta accreta: diagnosis and management: green-top guideline No. 27a","volume":"126","author":"Jauniaux","year":"2019","journal-title":"BJOG"},{"key":"R10-20230713","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","article-title":"Placenta accreta spectrum. Obstetric Care Consensus No. 7. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R11-20230713","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jogc.2018.12.004","article-title":"No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders","volume":"41","author":"Hobson","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"R12-20230713","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijgo.12408","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R13-20230713","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0000000000002434","article-title":"Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures","volume":"131","author":"Baldwin","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R14-20230713","doi-asserted-by":"crossref","first-page":"e52893","DOI":"10.1371\/journal.pone.0052893","article-title":"Incidence and risk factors for placenta accreta\/increta\/percreta in the UK: a national case-control study","volume":"7","author":"Fitzpatrick","year":"2012","journal-title":"PLoS One"},{"key":"R15-20230713","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7863\/jum.2010.29.1.157","article-title":"AIUM practice guideline for the performance of obstetric ultrasound examinations","volume":"29","year":"2010","journal-title":"J Ultrasound Med"},{"key":"R16-20230713","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/trf.12483","article-title":"Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation","volume":"54","author":"Brookfield","year":"2014","journal-title":"Transfusion"},{"key":"R17-20230713","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.ajog.2018.04.049","article-title":"Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta","volume":"219","author":"Marcellin","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20230713","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/j.ajog.2016.07.050","article-title":"Severe maternal morbidity: screening and review","volume":"215","author":"Kilpatrick","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20230713","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31826d60c5","article-title":"Severe maternal morbidity among delivery and postpartum hospitalizations in the United States","volume":"120","author":"Callaghan","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R20-20230713","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/AOG.0000000000002442","article-title":"Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta","volume":"131","author":"Shamshirsaz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R21-20230713","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/1471-0528.13579","article-title":"Does the presence of placental basal plate myometrial fibres increase the risk of subsequent morbidly adherent placenta: a case-control study","volume":"123","author":"Miller","year":"2015","journal-title":"BJOG"},{"key":"R22-20230713","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/AOG.0b013e3182051db2","article-title":"Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care","volume":"117","author":"Eller","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R23-20230713","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ajog.2020.01.034","article-title":"Characteristics and outcomes of placenta accreta spectrum in twins versus singletons: a study from the Pan American Society for Placenta Accreta Spectrum (PAS2)","volume":"222","author":"Shamshirsaz","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230713","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2011.01.040","article-title":"Predictors of massive blood loss in women with placenta accreta","volume":"205","author":"Wright","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20230713","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00404-019-05338-y","article-title":"Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa","volume":"300","author":"Mulla","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"R26-20230713","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T17:06:41Z","timestamp":1689268001000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003970","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}